Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The company has posted net profit of Rs.117.69 crores for FY 2020-21
The company reported total income of Rs.2441.54 crores during FY 2020-21
Lauryl alcohol prices rose sharply to Rs111 in Q4FY21
The first project of the collaboration focuses on the development of comprehensive pest monitoring and modelling for grapes and pome fruits, specifically apples
Acrylic resin is a plastic product that possesses excellent transparency and light resistance, and boasts a wide range of applications, including automotive light covers, signs, aquarium tanks, coatings and construction materials
The funds will be made available immediately to provide access to medical care and basic supplies in the hardest-hit countries
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
This marks Glenmark's first synthetic decapeptide injectable approval
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
I G Petrochemicals has reported total income of Rs.1126.94 crores during FY 2020-21
Balaji Amines has reported total income of Rs.1317.52 crores during FY 20-21
Consolidated revenue for the fourth quarter was up 26% YoY at Rs. 24,399 crore and EBITDA for Q4 FY21 surged 62% YoY to Rs. 5,142 crore
The companies are strengthening their collaboration in powder-based 3D printing
Grasim plans an investment in 200 TPD caustic brownfield expansion at Vilayat, Gujarat
Growing pragmatism about the safety of stocks in the chemical sector by top investment advisors stems from the fact that there is an increased demand in export markets and growth in specific Pharmaceutical segments
The acquisition of Chryso perfectly fits within Saint-Gobain’s strategic vision of worldwide leadership for sustainable construction
The deal is expected to close in June 2021
Subscribe To Our Newsletter & Stay Updated